Coronil, a medicine that claims to boost immunity against COVID-19, developed by yoga guru Ramdev-promoted Patanjali Ayurved has run into a controversy over claims of certification.
At the launch event on February 19 where Health Minister Harsh Vardhan and Union Minister Nitin Gadkari were also in attendance, the Patanjali product was billed by the company as the “first evidence-based medicine for COVID-19”.
WHO’s regional office for South-East Asia posted on its official Twitter handle, “@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.”
Patanjali Ayurveda managing director Acharya Balkrishna also took to Twitter and revealed that the Goods Manufacturing Practice (GMP) compliant Certificate of Pharmaceutical Product (CPP) to Coronil has been given by the Drugs Controller General of India (DCGI), as per previous reports.
